REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Sydna Farma (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Sydna Farma Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT Sydna Farma is based in Indonesia. The head office is in Central Jakarta. It operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on 1998. The total number of employees is currently 150 (estimated). In 2022, the company reported a net sales revenue increase of 17.16%. Its’ total assets recorded a growth of 16.19%.

Headquarters
Kota Jakarta Pusat Gondangdia Menteng Dki Jakarta
Central Jakarta; Jakarta; Postal Code: 10350

Contact Details: Purchase the PT Sydna Farma report to view the information.

Website: http://www.sydna-farma.com

Basic Information
Total Employees:
Purchase the PT Sydna Farma report to view the information.
Outstanding Shares:
Purchase the PT Sydna Farma report to view the information.
Registered Capital:
Purchase the PT Sydna Farma report to view the information.
Incorporation Date:
1998
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Sydna Farma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
17.16%
Total operating revenue
17.16%
Total assets
16.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?